{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:27:47Z","timestamp":1793212067931,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100024838","name":"Samsung Medical Center","doi-asserted-by":"crossref","award":["#SMX1221081"],"award-info":[{"award-number":["#SMX1221081"]}],"id":[{"id":"10.13039\/501100024838","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00248080"],"award-info":[{"award-number":["RS-2023-00248080"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68372-0","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:03:53Z","timestamp":1724828633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Histologic improvement predicts endoscopic remission in patients with ulcerative colitis"],"prefix":"10.1038","volume":"14","author":[{"given":"Ji Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ran","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Noh","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Kyung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Yun","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"68372_CR1","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","volume":"12","author":"GG Kaplan","year":"2015","unstructured":"Kaplan, G. G. The global burden of IBD: From 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 12, 720\u2013727. https:\/\/doi.org\/10.1038\/nrgastro.2015.150 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"68372_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"F Magro","year":"2017","unstructured":"Magro, F. et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J. Crohns Colitis 11, 649\u2013670. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx008 (2017).","journal-title":"J. Crohns Colitis"},{"key":"68372_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1053\/j.gastro.2016.09.046","volume":"152","author":"JF Colombel","year":"2017","unstructured":"Colombel, J. F., Narula, N. & Peyrin-Biroulet, L. Management strategies to improve outcomes of patients with inflammatory bowel diseases. Gastroenterology 152, 351-361.e355. https:\/\/doi.org\/10.1053\/j.gastro.2016.09.046 (2017).","journal-title":"Gastroenterology"},{"key":"68372_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1053\/j.gastro.2015.05.036","volume":"149","author":"T Dassopoulos","year":"2015","unstructured":"Dassopoulos, T. et al. Ulcerative colitis care pathway. Gastroenterology 149, 238\u2013245. https:\/\/doi.org\/10.1053\/j.gastro.2015.05.036 (2015).","journal-title":"Gastroenterology"},{"key":"68372_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5217\/ir.2021.00099","volume":"20","author":"A Sood","year":"2022","unstructured":"Sood, A., Mahajan, R., Singh, A., Midha, V. & Mehta, V. Endoscopy for assessment of mucosal healing in ulcerative colitis: Time bound or response guided?. Intest. Res. 20, 297\u2013302. https:\/\/doi.org\/10.5217\/ir.2021.00099 (2022).","journal-title":"Intest. Res."},{"key":"68372_CR6","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner, D. et al. STRIDE-II: An update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160, 1570\u20131583. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.031 (2021).","journal-title":"Gastroenterology"},{"key":"68372_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5217\/ir.2018.16.1.55","volume":"16","author":"V Narang","year":"2018","unstructured":"Narang, V. et al. Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis. Intest. Res. 16, 55\u201361. https:\/\/doi.org\/10.5217\/ir.2018.16.1.55 (2018).","journal-title":"Intest. Res."},{"key":"68372_CR8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/ibd\/izy300","volume":"25","author":"T Fukuda","year":"2019","unstructured":"Fukuda, T. et al. Efficacy of therapeutic intervention for patients with an ulcerative colitis mayo endoscopic score of 1. Inflamm. Bowel Dis. 25, 782\u2013788. https:\/\/doi.org\/10.1093\/ibd\/izy300 (2019).","journal-title":"Inflamm. Bowel Dis."},{"key":"68372_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/ecco-jcc\/jjv180","volume":"10","author":"P Boal Carvalho","year":"2016","unstructured":"Boal Carvalho, P., de Dias Castro, F., Rosa, B., Moreira, M. J. & Cotter, J. Mucosal healing in ulcerative colitis-when zero is better. J. Crohns Colitis 10, 20\u201325. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv180 (2016).","journal-title":"J. Crohns Colitis"},{"key":"68372_CR10","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1097\/mib.0000000000001275","volume":"23","author":"A Ponte","year":"2017","unstructured":"Ponte, A. et al. Impact of histological and endoscopic remissions on clinical recurrence and recurrence-free time in ulcerative colitis. Inflamm. Bowel Dis. 23, 2238\u20132244. https:\/\/doi.org\/10.1097\/mib.0000000000001275 (2017).","journal-title":"Inflamm. Bowel Dis."},{"key":"68372_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/ecco-jcc\/jjv158","volume":"10","author":"M Barreiro-de Acosta","year":"2016","unstructured":"Barreiro-de Acosta, M. et al. Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing (Mayo 0 vs. 1): A longitudinal cohort study. J. Crohns Colitis 10, 13\u201319. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv158 (2016).","journal-title":"J. Crohns Colitis"},{"key":"68372_CR12","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1177\/2050640617752207","volume":"6","author":"T Lobat\u00f3n","year":"2018","unstructured":"Lobat\u00f3n, T. et al. Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter study. United Eur. Gastroenterol. J. 6, 765\u2013772. https:\/\/doi.org\/10.1177\/2050640617752207 (2018).","journal-title":"United Eur. Gastroenterol. J."},{"key":"68372_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.cgh.2013.02.030","volume":"11","author":"L Rosenberg","year":"2013","unstructured":"Rosenberg, L. et al. Histologic markers of inflammation in patients with ulcerative colitis in clinical remission. Clin. Gastroenterol. Hepatol.: Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 11, 991\u2013996. https:\/\/doi.org\/10.1016\/j.cgh.2013.02.030 (2013).","journal-title":"Clin. Gastroenterol. Hepatol.: Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"68372_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0016-5085(92)90832-j","volume":"103","author":"K Geboes","year":"1992","unstructured":"Geboes, K. et al. Major histocompatibility class II expression on the small intestinal nervous system in Crohn\u2019s disease. Gastroenterology 103, 439\u2013447. https:\/\/doi.org\/10.1016\/0016-5085(92)90832-j (1992).","journal-title":"Gastroenterology"},{"key":"68372_CR15","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/ibd.21268","volume":"16","author":"BI Korelitz","year":"2010","unstructured":"Korelitz, B. I. Mucosal healing as an index of colitis activity: back to histological healing for future indices. Inflamm. Bowel Dis 16, 1628\u20131630. https:\/\/doi.org\/10.1002\/ibd.21268 (2010).","journal-title":"Inflamm. Bowel Dis"},{"key":"68372_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.crohns.2011.06.009","volume":"5","author":"L Peyrin-Biroulet","year":"2011","unstructured":"Peyrin-Biroulet, L. et al. Results from the 2nd scientific workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease. J. Crohns Colitis 5, 477\u2013483. https:\/\/doi.org\/10.1016\/j.crohns.2011.06.009 (2011).","journal-title":"J. Crohns Colitis"},{"key":"68372_CR17","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/ecco-jcc\/jjx103","volume":"11","author":"CM Leung","year":"2017","unstructured":"Leung, C. M. et al. Endoscopic and histological mucosal healing in ulcerative colitis in the first year of diagnosis: Results from a population-based inception cohort from six countries in Asia. J. Crohns Colitis 11, 1440\u20131448. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx103 (2017).","journal-title":"J. Crohns Colitis"},{"key":"68372_CR18","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.cgh.2019.12.011","volume":"18","author":"RK Pai","year":"2020","unstructured":"Pai, R. K. et al. Complete resolution of mucosal neutrophils associates with improved long-term clinical outcomes of patients with ulcerative colitis. Clin. Gastroenterol. Hepatol.: Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 18, 2510-2517.e2515. https:\/\/doi.org\/10.1016\/j.cgh.2019.12.011 (2020).","journal-title":"Clin. Gastroenterol. Hepatol.: Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"68372_CR19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/gutjnl-2015-309598","volume":"65","author":"RV Bryant","year":"2016","unstructured":"Bryant, R. V. et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut 65, 408\u2013414. https:\/\/doi.org\/10.1136\/gutjnl-2015-309598 (2016).","journal-title":"Gut"},{"key":"68372_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/gut.32.2.174","volume":"32","author":"SA Riley","year":"1991","unstructured":"Riley, S. A., Mani, V., Goodman, M. J., Dutt, S. & Herd, M. E. Microscopic activity in ulcerative colitis: What does it mean?. Gut 32, 174\u2013178. https:\/\/doi.org\/10.1136\/gut.32.2.174 (1991).","journal-title":"Gut"},{"key":"68372_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/1319-3767.80383","volume":"17","author":"S Azad","year":"2011","unstructured":"Azad, S., Sood, N. & Sood, A. Biological and histological parameters as predictors of relapse in ulcerative colitis: A prospective study. Saudi J. Gastroenterol. 17, 194\u2013198. https:\/\/doi.org\/10.4103\/1319-3767.80383 (2011).","journal-title":"Saudi J. Gastroenterol."},{"key":"68372_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1053\/gast.2001.20912","volume":"120","author":"A Bitton","year":"2001","unstructured":"Bitton, A. et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 120, 13\u201320. https:\/\/doi.org\/10.1053\/gast.2001.20912 (2001).","journal-title":"Gastroenterology"},{"key":"68372_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","volume":"133","author":"RB Gupta","year":"2007","unstructured":"Gupta, R. B. et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: A cohort study. Gastroenterology 133, 1099\u20131105. https:\/\/doi.org\/10.1053\/j.gastro.2007.08.001 (2007).","journal-title":"Gastroenterology"},{"key":"68372_CR24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/bf02233941","volume":"11","author":"R Wright","year":"1966","unstructured":"Wright, R. & Truelove, S. R. Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets. Am. J. Dig. Dis. 11, 847\u2013857. https:\/\/doi.org\/10.1007\/bf02233941 (1966).","journal-title":"Am. J. Dig. Dis."},{"key":"68372_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/DCR.0b013e31819ad456","volume":"52","author":"MM Hefti","year":"2009","unstructured":"Hefti, M. M., Chessin, D. B., Harpaz, N. H., Steinhagen, R. M. & Ullman, T. A. Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis. Dis. Colon Rectum 52, 193\u2013197. https:\/\/doi.org\/10.1007\/DCR.0b013e31819ad456 (2009).","journal-title":"Dis. Colon Rectum"},{"key":"68372_CR26","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/ajg.2012.301","volume":"107","author":"T Bessissow","year":"2012","unstructured":"Bessissow, T. et al. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am. J. Gastroenterol. 107, 1684\u20131692. https:\/\/doi.org\/10.1038\/ajg.2012.301 (2012).","journal-title":"Am. J. Gastroenterol."},{"key":"68372_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","volume":"126","author":"M Rutter","year":"2004","unstructured":"Rutter, M. et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126, 451\u2013459. https:\/\/doi.org\/10.1053\/j.gastro.2003.11.010 (2004).","journal-title":"Gastroenterology"},{"key":"68372_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/ibd\/izac075","volume":"29","author":"G Seong","year":"2023","unstructured":"Seong, G. et al. Histologic activity and steroid use history are risk factors of clinical relapse in ulcerative colitis with mayo endoscopic subscore of 0 or 1. Inflamm. Bowel Dis 29, 238\u2013244. https:\/\/doi.org\/10.1093\/ibd\/izac075 (2023).","journal-title":"Inflamm. Bowel Dis"},{"key":"68372_CR29","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/ajg.2016.418","volume":"111","author":"S Park","year":"2016","unstructured":"Park, S., Abdi, T., Gentry, M. & Laine, L. Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: Systematic review and meta-analysis. Am. J. Gastroenterol. 111, 1692\u20131701. https:\/\/doi.org\/10.1038\/ajg.2016.418 (2016).","journal-title":"Am. J. Gastroenterol."},{"key":"68372_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/apt.13948","volume":"45","author":"L Vuitton","year":"2017","unstructured":"Vuitton, L. et al. Defining endoscopic response and remission in ulcerative colitis clinical trials: An international consensus. Aliment. Pharmacol. Ther. 45, 801\u2013813. https:\/\/doi.org\/10.1111\/apt.13948 (2017).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"68372_CR31","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1053\/j.gastro.2023.02.031","volume":"164","author":"M Iacucci","year":"2023","unstructured":"Iacucci, M. et al. Artificial intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis. Gastroenterology 164, 1180-1188.e1182. https:\/\/doi.org\/10.1053\/j.gastro.2023.02.031 (2023).","journal-title":"Gastroenterology"},{"key":"68372_CR32","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1053\/j.gastro.2020.08.037","volume":"159","author":"K Li","year":"2020","unstructured":"Li, K. et al. Relationship between combined histologic and endoscopic endpoints and efficacy of ustekinumab treatment in patients with ulcerative colitis. Gastroenterology 159, 2052\u20132064. https:\/\/doi.org\/10.1053\/j.gastro.2020.08.037 (2020).","journal-title":"Gastroenterology"},{"key":"68372_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/apt.15568","volume":"51","author":"KC Cushing","year":"2020","unstructured":"Cushing, K. C., Tan, W., Alpers, D. H., Deshpande, V. & Ananthakrishnan, A. N. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission. Aliment. Pharmacol. Ther. 51, 347\u2013355. https:\/\/doi.org\/10.1111\/apt.15568 (2020).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"68372_CR34","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/gut.47.3.404","volume":"47","author":"K Geboes","year":"2000","unstructured":"Geboes, K. et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47, 404\u2013409. https:\/\/doi.org\/10.1136\/gut.47.3.404 (2000).","journal-title":"Gut"},{"key":"68372_CR35","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cgh.2013.07.022","volume":"12","author":"L Peyrin-Biroulet","year":"2014","unstructured":"Peyrin-Biroulet, L., Bressenot, A. & Kampman, W. Histologic remission: The ultimate therapeutic goal in ulcerative colitis?. Clin. Gastroenterol. Hepatol.: Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 12, 929-934.e922. https:\/\/doi.org\/10.1016\/j.cgh.2013.07.022 (2014).","journal-title":"Clin. Gastroenterol. Hepatol.: Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"68372_CR36","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/ibd\/izz308","volume":"26","author":"D Kevans","year":"2020","unstructured":"Kevans, D. et al. Histological markers of clinical relapse in endoscopically quiescent ulcerative colitis. Inflamm. Bowel Dis. 26, 1722\u20131729. https:\/\/doi.org\/10.1093\/ibd\/izz308 (2020).","journal-title":"Inflamm. Bowel Dis."},{"key":"68372_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ibd\/izaa048","volume":"27","author":"MT Osterman","year":"2021","unstructured":"Osterman, M. T. et al. Endoscopic and histological assessment, correlation, and relapse in clinically quiescent ulcerative colitis (MARQUEE). Inflamm. Bowel Dis. 27, 207\u2013214. https:\/\/doi.org\/10.1093\/ibd\/izaa048 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"68372_CR38","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.cgh.2013.06.023","volume":"11","author":"DT Rubin","year":"2013","unstructured":"Rubin, D. T. et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: A case-control study. Clin. Gastroenterol. Hepatol.: Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 11, 1601\u20131608. https:\/\/doi.org\/10.1016\/j.cgh.2013.06.023 (2013).","journal-title":"Clin. Gastroenterol. Hepatol.: Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"68372_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/ibd\/izab130","volume":"28","author":"SR Shaffer","year":"2022","unstructured":"Shaffer, S. R. et al. Achieving histologic normalization in ulcerative colitis is associated with a reduced risk of subsequent dysplasia. Inflamm. Bowel Dis. 28, 553\u2013559. https:\/\/doi.org\/10.1093\/ibd\/izab130 (2022).","journal-title":"Inflamm. Bowel Dis."},{"key":"68372_CR40","doi-asserted-by":"publisher","first-page":"S287","DOI":"10.14309\/00000434-200509001-00789","volume":"100","author":"K Geboes","year":"2005","unstructured":"Geboes, K. et al. Infliximab results in reduction of inflammation and inflammatory markers in the mucosa of ulcerative colitis patients: The ACT 1 trial (abstr). Am. J. Gastroenterol. 100, S287 (2005).","journal-title":"Am. J. Gastroenterol."},{"key":"68372_CR41","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/apt.13375","volume":"42","author":"A Marchal Bressenot","year":"2015","unstructured":"Marchal Bressenot, A. et al. Review article: The histological assessment of disease activity in ulcerative colitis. Aliment. Pharmacol. Ther. 42, 957\u2013967. https:\/\/doi.org\/10.1111\/apt.13375 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"68372_CR42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/ecco-jcc\/jjaa206","volume":"15","author":"P Bossuyt","year":"2021","unstructured":"Bossuyt, P., Bisschops, R., Vermeire, S. & De Hertogh, G. Variability in the distribution of histological disease activity in the colon of patients with ulcerative colitis. J. Crohns Colitis 15, 603\u2013608. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa206 (2021).","journal-title":"J. Crohns Colitis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68372-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68372-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68372-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:09:45Z","timestamp":1724828985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68372-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68372"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68372-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"29 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19926"}}